Hormone oscillations in the HPA axis: dynamical diseases and beyond

Abstract

Aim: Hormone pulsatility is an important aspect of the hypothalamic-pituitary-adrenal (HPA) axis in health and disease. We use the properties of simple mathematical models to determine whether hormone pulsatility reflects the presence of a time delay in the production of hormones and/or is related to the impulsive nature of hormone secretion. Methods: The predictions of two models for HPA pulsatility are compared. The first model assumes pulsatility arises because of a time delay in the synthesis of glucocorticoids (GCs). The second model suggests that pulsatility reflects the impulsive nature of hormone secretion. The generation of oscillations by the second mechanism does not require a time delay. Results: The time delay for the synthesis of GC (0–10 minutes) may not be long enough to account for the oscillations in adrenocorticotrophin (ACTH) and GC observed with constant corticotrophin-releasing hormone (CRH) infusion in rats. A simple mechanism for hormone release, illustrated using an integrate-and-fire mechanism, reproduces the observed hormone pulsatility. Conclusions: The water solubility of CRH and ACTH draws attention to the role played by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins in the calcium-dependent exocytosis of peptide hormones. Abnormalities in SNARE proteins are anticipated to cause changes in the amplitude modulation of ACTH and CRH hormone pulses. In mice, a mutation in a SNARE protein causes abnormalities in the HPA axis. Mutations in SNARE proteins occur in many neurodegenerative and neuropsychiatric diseases. Abnormalities in HPA function also occur in these disorders. The identification of SNARE protein mutations in exosomes in serum and cerebrospinal fluid in humans may make it possible to determine whether there exists a causal relationship between an SNARE protein mutation and abnormalities in the HPA axis in this patient group.

Keywords

Hypothalamic-pituitary-adrenal axis / pulsatility / time delay / secretion / soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins

References

[1] Milton JG, Gotman J, Remillard GM, Andermann F. Timing of seizure recurrence in adult epileptic patients: a statistical analysis. Epilepsia. 1987; 28: 471-8.

[2] Karoly PJ, Rao VR, Gregg NM, Worrell GA, Bernard C, Cook MJ, et al. Cycles in epilepsy. Nat Rev Neurol. 2021; 17: 267-84.

[3] DUBOIS FS. Rhythms, cycles and periods in health and disease. Am J Psychiatry. 1959; 116: 114-9.

[4] Reimann HA. Periodic diseases. Philadelphia: FA Davis Co; 1963.

[5] Richter CP. BIOLOGICAL CLOCKS IN MEDICINE AND PSYCHIATRY: SHOCK-PHASE HYPOTHESIS. Proc Natl Acad Sci U S A. 1960; 46: 1506-30.

[6] Mackey MC, an der Heiden U. Dynamical diseases and bifurcations: Understanding functional disorders in physiological systems. Funkt Biol Med. 1982; 1: 156-64.

[7] Mackey MC, Milton JG. Dynamical diseases. Ann N Y Acad Sci. 1987; 504: 16-32.

[8] Baier G, Milton J. Dynamic diseases of the brain. In: Jaeger D, Jung R, editors. Encyclopedia of Computational Neuroscience. New York: Springer; 2020. pp. 1243-55.

[9] Lightman SL, Birnie MT, Conway-Campbell BL. Dynamics of ACTH and Cortisol Secretion and Implications for Disease. Endocr Rev. 2020; 41: bnaa002.

[10] Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci. 2010; 11: 710-8.

[11] Ma L, Chen Y, Chen H, Liu Y, Wang Y. The function of hypothalamus-pituitary-adrenal axis in children with ADHD. Brain Res. 2011; 1368: 159-62.

[12] Pinto R, Rijsdijk F, Ouellet-Morin I, Asherson P, McLoughlin G, Kuntsi J. The aetiological association between the dynamics of cortisol productivity and ADHD. J Neural Transm (Vienna). 2016; 123: 991-1000.

[13] Spataro R, Volanti P, Vitale F, Meli F, Colletti T, Di Natale A, et al. Plasma cortisol level in amyotrophic lateral sclerosis. J Neurol Sci. 2015; 358: 282-6.

[14] Mentis AA, Bougea AM, Chrousos GP. Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored? Aging Brain. 2021; 1: 100024.

[15] Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimer’s and Parkinson’s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging. 1997; 18: 285-9.

[16] Popp J, Wolfsgruber S, Heuser I, Peters O, Hüll M, Schröder J, et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer’s type. Neurobiol Aging. 2015; 36: 601-7.

[17] Ishii M, Iadecola C. Metabolic and Non-Cognitive Manifestations of Alzheimer’s Disease: The Hypothalamus as Both Culprit and Target of Pathology. Cell Metab. 2015; 22: 761-76.

[18] Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, et al. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab. 1985; 61: 429-38.

[19] Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, et al. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab. 1987; 65: 141-52.

[20] Young EA, Carlson NE, Brown MB. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology. 2001; 25: 267-76.

[21] Bartlett DM, Cruickshank TM, Hannan AJ, Eastwood PR, Lazar AS, Ziman MR. Neuroendocrine and neurotrophic signaling in Huntington’s disease: Implications for pathogenic mechanisms and treatment strategies. Neurosci Biobehav Rev. 2016; 71: 444-54.

[22] Van Cauter E, Linkowski P, Kerkhofs M, Hubain P, L’Hermite-Balériaux M, Leclercq R, et al. Circadian and sleep-related endocrine rhythms in schizophrenia. Arch Gen Psychiatry. 1991; 48: 348-56.

[23] Kogler L, Wang R, Luther T, Hofer A, Frajo-Apor B, Derntl B. Cortisol in schizophrenia spectrum disorders: A comprehensive meta-analysis. Front Neuroendocrinol. 2025; 77: 101186.

[24] Karin O, Raz M, Tendler A, Bar A, Kohanim YK, Milo T, et al. A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks. Mol Syst Biol. 2020; 16: e9510.

[25] Martin TFJ. Control of hormone secretion. In: Jameson JL, de Groot L, editors. Endocrinology: Adult and Pediatric. New York: Elsevier; 2010. pp. 30-40.

[26] Jahn R, Cafiso DC, Tamm LK. Mechanisms of SNARE proteins in membrane fusion. Nat Rev Mol Cell Biol. 2024; 25: 101-18.

[27] Chen F, Chen H, Chen Y, Wei W, Sun Y, Zhang L, et al. Dysfunction of the SNARE complex in neurological and psychiatric disorders. Pharmacol Res. 2021; 165: 105469.

[28] Margiotta A. Role of SNAREs in Neurodegenerative Diseases. Cells. 2021; 10: 991.

[29] Fujiwara T, Kofuji T, Akagawa K. Dysfunction of the hypothalamic-pituitary-adrenal axis in STX1A knockout mice. J Neuroendocrinol. 2011; 23: 1222-30.

[30] Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 1996; 17: 221-44.

[31] Terry JR, Walker JJ, Spiga F, Lightman SL. Dynamics of the HPA axis: A system modeling approach. In: MacGregor DJ, Leng G, editors. Computational Endocrinology. Hoboken: John Wiley & Sons; 2016. pp. 252-83.

[32] Walker JJ, Terry JR, Lightman SL. Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis. Proc Biol Sci. 2010; 277: 1627-33.

[33] Churilov AN, Milton J, Salakhova ER. An integrate-and-fire model for pulsatility in the neuroendocrine system. Chaos. 2020; 30: 083132.

[34] Churilov AN, Milton JG. Modeling pulsativity in the hypothalamic-pituitary-adrenal hormonal axis. Sci Rep. 2022; 12: 8480.

[35] Churilov AN, Milton JG. An integrate-and-fire mechanism for modeling rhythmicity in the neuroendocrine system. In: Mau J, Mukhin S, Wang S, Xu S, editors. BIOKYBERNETIKA: Mathematics for theory and control in the human and in society. Berlin, Boston: de Gruyter; 2025. pp. 2379-88.

[36] Milton J, Churilov A. Modeling pulsativity in the hypothalamic-pituitary-adrenal axis. In: 5th Edition of World Congress on Endocrinology, Diabetes and Metabolism; 2024 Jul 15-16. Vienna, Austria. p. 151.

[37] Yamalova D, Abdirasulov AZ. Ultradian rhythmicity and chaotic behaviors in the integrate-and-fire model of the neuroendocrine system. Intern J Bifurc Chaos. 2022; 32: 2250205.

[38] Hayes ND. Roots of the transcendental equation associated with a certain difference-differential equation. J Lond Math Soc. 1950; 25: 226-32.

[39] Longtin A, Milton JG. Modelling autonomous oscillations in the human pupil light reflex using non-linear delay-differential equations. Bull Math Biol. 1989; 51: 605-24.

[40] Mackey MC. Periodic auto-immune hemolytic anemia: an induced dynamical disease. Bull Math Biol. 1979; 41: 829-34.

[41] Wright E. A non-linear difference-differential equation. J Reine Angew Math. 1955; 194: 66-87.

[42] Lake RB, Gann DS. Dynamic response of the intact canine adrenal to infused ACTH. Ann Biomed Eng. 1972; 1: 56-68.

[43] Urquhart J, Li CC. The dynamics of adrenocortical secretion. Am J Physiol. 1968; 214: 73-85.

[44] Papaikonomou E. Rat adrenocortical dynamics. J Physiol. 1977; 265: 119-31.

[45] Walker JJ, Spiga F, Waite E, Zhao Z, Kershaw Y, Terry JR, et al. The origin of glucocorticoid hormone oscillations. PLoS Biol. 2012; 10: e1001341.

[46] Tsai TY, Choi YS, Ma W, Pomerening JR, Tang C, Ferrell Jr JE. Robust, tunable biological oscillations from interlinked positive and negative feedback loops. Science. 2008; 321: 126-9.

[47] Artalejo CR, Elhamdani A, Palfrey HC. Secretion: dense-core vesicles can kiss-and-run too. Curr Biol. 1998; 8: R62-5.

[48] Loh YP, Xiao L, Park JJ. Trafficking of hormones and trophic factors to secretory and extracellular vesicles: a historical perspective and new hypothesis. Extracell Vesicles Circ Nucl Acids. 2023; 4: 568-87.

[49] Singh AV, Raymond M, Pace F, Certo A, Zuidema JM, McKay CA, et al. Astrocytes increase ATP exocytosis mediated calcium signaling in response to microgroove structures. Sci Rep. 2015; 5: 7847.

[50] Jena BP. Secretion machinery at the cell plasma membrane. Curr Opin Struct Biol. 2007; 17: 437-43.

[51] Jena BP. ‘Porosome’ discovered nearly 20 years ago provides molecular insights into the kiss-and-run mechanism of cell secretion. J Cell Mol Med. 2015; 19: 1427-40.

[52] Arora S, Saarloos I, Kooistra R, van de Bospoort R, Verhage M, Toonen RF. SNAP-25 gene family members differentially support secretory vesicle fusion. J Cell Sci. 2017; 130: 1877-89.

[53] Hoogstraaten RI, van Keimpema L, Toonen RF, Verhage M. Tetanus insensitive VAMP2 differentially restores synaptic and dense core vesicle fusion in tetanus neurotoxin treated neurons. Sci Rep. 2020; 10: 10913.

[54] Puntman DC, Arora S, Farina M, Toonen RF, Verhage M. Munc18-1 Is Essential for Neuropeptide Secretion in Neurons. J Neurosci. 2021; 41: 5980-93.

[55] Shimojo M, Courchet J, Pieraut S, Torabi-Rander N, Sando R 3rd, Polleux F, et al. SNAREs Controlling Vesicular Release of BDNF and Development of Callosal Axons. Cell Rep. 2015; 11: 1054-66.

[56] Yang X, Tu W, Gao X, Zhang Q, Guan J, Zhang J. Functional regulation of syntaxin-1: An underlying mechanism mediating exocytosis in neuroendocrine cells. Front Endocrinol (Lausanne). 2023; 14: 1096365.

[57] Kabachinski G, Kielar-Grevstad DM, Zhang X, James DJ, Martin TFJ. Resident CAPS on dense-core vesicles docks and primes vesicles for fusion. Mol Biol Cell. 2016; 27: 654-68.

[58] Grishanin RN, Kowalchyk JA, Klenchin VA, Ann K, Earles CA, Chapman ER, et al. CAPS acts at a prefusion step in dense-core vesicle exocytosis as a PIP2 binding protein. Neuron. 2004; 43: 551-62.

[59] Edwards RH. Neurotransmitter release: variations on a theme. Curr Biol. 1998; 8: R883-5.

[60] Kádková A, Murach J, Østergaard M, Malsam A, Malsam J, Lolicato F, et al. SNAP25 disease mutations change the energy landscape for synaptic exocytosis due to aberrant SNARE interactions. Elife. 2024; 12: RP88619.

[61] Agliardi C, Guerini FR, Zanzottera M, Bianchi A, Nemni R, Clerici M. SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s Disease. Mol Neurobiol. 2019; 56: 5792-8.

[62] Liu C, Liu D, Wang S, Gan L, Yang X, Ma C. Identification of the SNARE complex that mediates the fusion of multivesicular bodies with the plasma membrane in exosome secretion. J Extracell Vesicles. 2023; 12: e12356.

[63] Brinkmalm A, Brinkmalm G, Honer WG, Frölich L, Hausner L, Minthon L, et al. SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease. Mol Neurodegener. 2014; 9: 53.

[64] Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML. Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol. 1989; 257: E6-14.

[65] Iranmanesh A, Lizarralde G, Short D, Veldhuis JD. Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. J Clin Endocrinol Metab. 1990; 71: 1276-83.

[66] Carnes M, Brownfield MS, Kalin NH, Lent S, Barksdale CM. Episodic secretion of ACTH in rats. Peptides. 1986; 7: 219-23.

[67] Carnes M, Kalin NH, Lent SJ, Barksdale CM, Brownfield MS. Pulsatile ACTH secretion: variation with time of day and relationship to cortisol. Peptides. 1988; 9: 325-31.

[68] Gambacciani M, Liu JH, Swartz WH, Tueros VS, Rasmussen DD, Yen SS. Intrinsic pulsatility of ACTH release from the human pituitary in vitro. Clin Endocrinol (Oxf). 1987; 26: 557-63.

[69] Waite EJ, McKenna M, Kershaw Y, Walker JJ, Cho K, Piggins HD, et al. Ultradian corticosterone secretion is maintained in the absence of circadian cues. Eur J Neurosci. 2012; 36: 3142-50.

[70] Henley DE, Leendertz JA, Russell GM, Wood SA, Taheri S, Woltersdorf WW, et al. Development of an automated blood sampling system for use in humans. J Med Eng Technol. 2009; 33: 199-208.

[71] Faghih RT, Dahleh MA, Adler GK, Klerman EB, Brown EN. Quantifying Pituitary-Adrenal Dynamics and Deconvolution of Concurrent Cortisol and Adrenocorticotropic Hormone Data by Compressed Sensing. IEEE Trans Biomed Eng. 2015; 62: 2379-88.

[72] Upton TJ, Zavala E, Methlie P, Kämpe O, Tsagarakis S, Øksnes M, et al. High-resolution daily profiles of tissue adrenal steroids by portable automated collection. Sci Transl Med. 2023; 15: eadg8464.

[73] Singh SL, Chauhan K, Bharadwaj AS, Kishore V, Laux P, Luch A, et al. Polymer Translocation and Nanopore Sequencing: A Review of Advances and Challenges. Int J Mol Sci. 2023; 24: 6153.

[74] Russell G, Lightman S. The human stress response. Nat Rev Endocrinol. 2019; 15: 525-34.

[75] Justice NJ. The relationship between stress and Alzheimer’s disease. Neurobiol Stress. 2018; 8: 127-33.

[76] Burek K, Rabstein S, Kantermann T, Vetter C, Wang-Sattler R, Lehnert M, et al. Altered coordination between sleep timing and cortisol profiles in night working female hospital employees. Psychoneuroendocrinology. 2024; 166: 107066.

[77] Doane LD, Adam EK. Loneliness and cortisol: momentary, day-to-day, and trait associations. Psychoneuroendocrinology. 2010; 35: 430-41.

[78] Weinrib AZ, Sephton SE, Degeest K, Penedo F, Bender D, Zimmerman B, et al. Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer. 2010; 116: 4410-9.